Ireland-based CRO Icon has agreed, subject to certain closing conditions, to acquire Aptiv Solutions for $143.5m in cash to further expand its adaptive trial offerings.
Ireland-based CRO Icon unveiled higher than expected revenue and backlog increases in 2012 when compared to 2011, and the company expects even stronger results in 2013.
Ireland-based CRO Icon says acquisition of Chinese trial firm BeijingWits Medical Consulting will boost capabilities in the country and help meet growing demand from global clients.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving ClinTec, Synexus,
Tripos, Qualia, Icon, and Encorium Group.
